Medline (FRA:L10) Total Equity: €16,737 Mil (As of Mar. 2026)


FRA:L10 Medline Inc FRA:L10
14 GF Score
Price €32.60
! 3 Warning Signs
View Full Analysis

What is Medline Total Equity?

Medline FRA:L10 +5.16% 14 Total Equity is €16,737 Mil as of Mar. 2026. GuruFocus rates FRA:L10 with a GF Score™ of 14/100. The stock has 3 warning signs investors should review.

Medline's total equity for the quarter that ended in Mar. 2026 was €16,737 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Medline Total Equity Historical Data

* Premium members only.

The historical data trend for Medline's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medline Total Equity Chart

Medline Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Total Equity
0.00 15,567.91 15,780.42 16,470.24

Medline Quarterly Data
Dec23 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only 0.00 14,696.52 14,604.13 16,470.24 16,736.89
FRA:L10
14GF Score
Medline Inc FRA:L10
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medline Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Medline's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=32865.336-16395.092
=16,470

Medline's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=33747.11-17010.225
=16,737

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of €16,737 Mil mean?
Medline (FRA:L10) has a Total Equity of €16,737 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Medline and its competitors.
Is Medline's Total Equity too high?
Medline's current Total Equity is €16,737 Mil. Overall, Medline has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Medline's Total Equity compare to RMD and WST?
Medline's Total Equity of €16,737 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Devices & Instruments company?
A good Total Equity depends on the Medical Devices & Instruments industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Medline and its competitors. Medline's current Total Equity is €16,737 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medline stock overvalued right now?
Medline (FRA:L10) has a current Total Equity of €16,737 Mil. The current Total Equity is €16,737 Mil. Medline's overall GF Score™ is 14/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Medline (FRA:L10), the current Total Equity is €16,737 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medline Business Description

Other Exchanges MDLN:USA
Address 3 Lakes Drive, Northfield, IL, USA, 60093
Medline is the largest provider of medical-surgical products and supply chain solutions in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front-line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.
14GF Score

Get the complete analysis for FRA:L10

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€32.60
Price